» Articles » PMID: 35672694

Effect of Chronic Intermittent Hypoxia-induced HIF-1α/ATAD2 Expression on Lung Cancer Stemness

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Obstructive sleep apnea is associated with increased lung cancer incidence and mortality. Cancer stem cells (CSCs) are characterized by their self-renewing ability, which contributes to metastasis, recurrence, and drug resistance. ATPase family AAA domain-containing protein 2 (ATAD2) induces malignancy in different types of tumors. However, a correlation between ATAD2 expression and CSCs in lung cancer has not yet been reported.

Methods: The relative messenger RNA (mRNA) levels of ATAD2, CD44, CD133, and hypoxia-inducible factor (HIF)-1α were determined using reverse-transcription quantitative polymerase chain reaction. ATAD2 protein levels were determined using Western blotting. Cell counting kit-8, 5-ethynyl-2'-deoxyuridine (EdU), and colony formation assays were performed to analyze the proliferation of lung cancer cells. Transwell migration and invasion assays were performed to evaluate cell migration and invasion, respectively. Tumor sphere formation analysis was used to determine tumor spheroid capacity. The link between ATAD2 and HIF-1α was verified using a dual-luciferase reporter assay. Immunofluorescence staining was performed to assess mitochondrial reactive oxygen species (mtROS) production. Flow cytometry analysis was conducted to determine the CD133 and CD44 positive cell ratio.

Results: We evaluated the relative expression of ATAD2 in four lung cancer cell lines (A549, SPC-A1, H460, and H1299 cells) and found increased mRNA and protein levels of ATAD2 in lung cancer samples. ATAD2 overexpression was a poor prognostic factor for lung cancer patients. Loss of ATAD2 reduced lung cancer cell viability and proliferation. Additionally, ATAD2 knockdown repressed lung cancer cell migration, invasion, stem-cell-like properties, and mtROS production. Chronic intermittent hypoxia (CIH)-induced HIF-1α expression significantly activated ATAD2 during lung cancer progression.

Conclusions: This study found that CIH induced HIF-1α expression, which acts as a transcriptional activator of ATAD2. The present study also suggests a novel mechanism by which the integrity of CIH-triggered HIF-1α/ATAD2 may determine lung cancer aggressiveness via the interplay of mtROS and stemness in lung cancer cells.

Citing Articles

Multi-stage mechanisms of tumor metastasis and therapeutic strategies.

Liu Z, Chen J, Ren Y, Liu S, Ba Y, Zuo A Signal Transduct Target Ther. 2024; 9(1):270.

PMID: 39389953 PMC: 11467208. DOI: 10.1038/s41392-024-01955-5.


Mechanistic prediction and validation of Brevilin A Therapeutic effects in Lung Cancer.

Wang R, Gao C, Yu M, Song J, Feng Z, Wang R BMC Complement Med Ther. 2024; 24(1):214.

PMID: 38840248 PMC: 11151568. DOI: 10.1186/s12906-024-04516-z.


A review of obstructive sleep apnea and lung cancer: epidemiology, pathogenesis, and therapeutic options.

Yuan F, Hu Y, Xu F, Feng X Front Immunol. 2024; 15:1374236.

PMID: 38605948 PMC: 11007033. DOI: 10.3389/fimmu.2024.1374236.


Genomic analysis of hypoxia and mitophagy related genes with prognosis and characterization of the immune microenvironment in LUAD.

Liu J, Huang H, Han Y, Hua Y, Li B, Liu H J Cancer. 2024; 15(5):1342-1354.

PMID: 38356715 PMC: 10861832. DOI: 10.7150/jca.91762.


Is obstructive sleep apnea a risk factor for lung cancer?-from pathophysiological mechanisms to clinical data.

Martinez-Garcia M, Oscullo G, Gomez-Olivas J, Ingles-Azorin M, Mompean S Ann Transl Med. 2024; 11(12):422.

PMID: 38213801 PMC: 10777209. DOI: 10.21037/atm-23-1641.


References
1.
Boussouar F, Jamshidikia M, Morozumi Y, Rousseaux S, Khochbin S . Malignant genome reprogramming by ATAD2. Biochim Biophys Acta. 2013; 1829(10):1010-4. DOI: 10.1016/j.bbagrm.2013.06.003. View

2.
Wang M, Zhao X, Zhu D, Liu T, Liang X, Liu F . HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment. J Exp Clin Cancer Res. 2017; 36(1):60. PMC: 5408450. DOI: 10.1186/s13046-017-0533-1. View

3.
Gao X, Jia Z, Zhao F, An D, Wang B, Cheng E . Obstructive sleep apnea syndrome and causal relationship with female breast cancer: a mendelian randomization study. Aging (Albany NY). 2020; 12(5):4082-4092. PMC: 7093176. DOI: 10.18632/aging.102725. View

4.
Mirantes C, Espinosa I, Ferrer I, Dolcet X, Prat J, Matias-Guiu X . Epithelial-to-mesenchymal transition and stem cells in endometrial cancer. Hum Pathol. 2013; 44(10):1973-81. DOI: 10.1016/j.humpath.2013.04.009. View

5.
Moulin S, Thomas A, Arnaud C, Arzt M, Wagner S, Maier L . Cooperation Between Hypoxia-Inducible Factor 1α and Activating Transcription Factor 4 in Sleep Apnea-Mediated Myocardial Injury. Can J Cardiol. 2020; 36(6):936-940. DOI: 10.1016/j.cjca.2020.04.002. View